Skip to content
Skip to footer

About

Guided by our values, we are an impact-driven organization that improves care in every setting – one product, one partner, one patient at a time.

Explore
- Explore Newsroom
- Press Releases
Commitments

Through our core commitments, we are leveraging our scale for the greater good, such as serving the needs of our stakeholders, donating back to our communities, protecting our planet, working with policymakers, and more.

Explore

Discover Our Impact

Every year, we publish updates to our commitments through our Impact Report.
Download Our Impact Report
- Explore McKesson Foundation
- McKesson Taking Care of Our Own Fund
Business Solutions

Our businesses bring together leading technologies, innovative solutions and hands-on expertise to support the entire healthcare ecosystem.

Explore

All Businesses Listings

Take a look at our list of businesses.
Our Businesses
- Pharmaceutical, Medical Supplies & Products Distribution Services
  
  We distribute pharmaceuticals and medical supplies to healthcare settings across North America, from pharmacies and hospitals to doctors’ offices and clinics.
  
  Pharmaceutical Distribution Services
  
  Medical Supply Distribution
- Pharmacy Services
  
  We help to ensure the financial wellbeing of pharmacies and health systems and support a stable work environment for their employees.
- Oncology & Multispecialty Solutions
  
  We provide research, insights, technologies and other support to help address challenges in cancer and specialty care.
- Biopharma Capabilities
  
  We provide a suite of solutions designed to address access, affordability and adherence challenges by bridging the gaps between biopharma companies, pharmacies, providers, and payers to help patients get on and stay on their medications.
- Prescription Benefit Solutions
  
  We offer solutions that enable employers, payers, health-plan brokers and government agencies to provide lower-cost options for prescription medications and therapies.
- Consumer Products & Services
  
  We help to ensure the financial wellbeing of pharmacies and health systems and support a stable work environment for their employees.
Stories & Insights

Advancing Precision and Personalized Medicine

Learn how precision and personalized medicine are helping expand access to clinical trials and novel treatments in communities.

Read Time

3.5 minutes

Key Points

Precision and personalized medicine are transforming cancer care and expanding access to clinical trials and novel treatments in communities.
This Always Advancing episode features Dr. Andrew McKenzie, PhD, vice president of personalized medicine at Sarah Cannon Research Institute (SCRI).
The video highlights how McKesson is helping lead the precision medicine revolution through data-driven insights and purpose-driven collaboration with biopharma.
Our Always Advancing series shares how we help our biopharma partners bridge the divide between today’s challenges and tomorrow’s breakthroughs so more patients can get the care they need.

How is McKesson helping advance precision and personalized medicine?

McKesson is helping advance precision and personalized medicine through data-driven insights and collaboration with biopharma that support access to clinical trials and novel treatments in communities.

Who you’ll hear from

Dr. Andrew McKenzie, PhD, vice president of Personalized Medicine, Sarah Cannon Research Institute (SCRI)

About Always Advancing:

From navigating the stages of research and development and engaging diverse populations in clinical trials to enabling patient access to prescribed therapies and beyond, the healthcare landscape has never been more complex or more promising for improving the lives of patients.

Our Always Advancing series shares how we help our biopharma partners bridge the divide between today’s challenges and tomorrow’s breakthroughs, so more patients can get the care they need.

Related Stories

Gloved hand holding a vial with DNA and biotechnology icons overlaid.

Cracking the Cost-Density Code

While payer confidence in the science is growing, reimbursement complexity, data gaps and system misalignment remain barriers to broader cell and gene therapy access.

Healthcare professional using a tablet with a digital data network overlay.

Linked Oncology Data is Becoming a Biopharma Priority

A 2026 survey of 100 senior-level life sciences professionals suggests the next opportunity in oncology real-world data is not simply more data, but linked data that is trusted, timely and ready to support stronger clinical and commercial decisions.

Person undergoing an eye exam with a slit-lamp microscope as a clinician examines the eye in a medical setting.

Supporting Community-based Ophthalmology Providers

How PRISM Vision Group helps streamline operations, enhance clinical care and support ophthalmology and retina practices.

Pharmacist in a retail pharmacy consults with a customer in front of shelves stocked with prescription medications.

EnterpriseRx® Is Built for Modern Pharmacy Operations

A McKesson Pharmacy Systems technology tool designed to help pharmacy teams operate efficiently today while preparing for future

Clinician with stethoscope shows tablet to older patient in exam room; medical charts visible on wall.

Improving Patient Access Through Community Oncology

Community oncology is expanding access to advanced cancer care by bringing precision medicine, clinical research and technology-enabled support closer to where patients live and receive ongoing treatment.

Two healthcare professionals review a tablet together; one wears a stethoscope, standing in a modern clinical or office setting.

Care Close to Home Is the Goal

Explore how The US Oncology Network is shaping the future of community oncology through collaboration, innovation and partnership.

Two speakers seated at a panel table with microphones; one speaks while another listens. A backdrop reads “AXS… Access to Pharmacy” and a glass pitcher sits nearby.

Navigating Complexity to Advance Patient Access

Insights from two McKesson-led discussions on collaboration and reimbursement at Asembia’s AXS26 Summit.

Person in white blouse and blue skirt leans forward to shake hands with another person across a desk in a modern office.

How Specialty Group Purchasing Organizations Support Independent Care

McKesson’s GPOs empower independent healthcare providers to access differentiated contract pricing and terms, navigate rising drug costs and sustain community-based care.

Healthcare worker gives an injection to an adult seated in a chair, resting a hand on the person's shoulder in a clinical room.

What Real-World Evidence Reveals About Early-Onset Colorectal Cancer

Leveraging data from the largest community oncology networks, we look at factors increasing colorectal cancer in younger patients.

Two lab professionals in white coats review data on a computer monitor in a lab, one pointing at the screen. InspiroGene by McKesson logos visible.

Providing Channel Optionality for Cell and Gene Therapies

How treatment centers can access CGTs through two different channel strategies — Buy-and-Bill and Specialty Pharmacy.

Related Tags